RIGEL PHARMACEUTICALS INC (RIGL)

Sentiment-Signal

23,5
Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
6.2
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)

Score-Verlauf (90 Tage)

Stammdaten

Rigel Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs to treat hematologic disorders, cancer, and rare immune diseases. The company offers Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia. It also develops Fostamatinib that is in phase III clinical trial for the treatment of warm autoimmune hemolytic anemia; phase III clinical trial for the treatment of hospitalized COVID-19 patients; and phase III clinical trial for the treatment of COVID-19. In addition, the company is developing R289, an oral interleukin receptor associated kinase 1/4 inhibitor, which is in phase I clinical trial for autoimmune, inflammatory, and hematology-oncology diseases; and R552, a receptor-interacting serine/threonine-protein kinase 1 inhibitor that has completed phase I clinical trial for autoimmune and inflammatory diseases. It has research and license agreements with AstraZeneca AB for the development and commercialization of R256, an inhaled JAK inhibitor; BerGenBio AS for the development and commercialization of AXL inhibitors in oncology; and Daiichi Sankyo to develop murine double minute 2 inhibitors for solid and hematological malignancies, as well as license and supply agreement with Kissei Pharmaceutical Co., Ltd. to develop and commercialize Fostamatinib. The company also has a license agreement and strategic collaboration with Eli Lilly and Company to co-develop and commercialize R552 for various indications, including autoimmune and inflammatory diseases, as well as other non-central nervous system (non-CNS) disease development candidates. Rigel Pharmaceuticals, Inc. was incorporated in 1996 and is headquartered in South San Francisco, California.

Unternehmen & Branche

NameRIGEL PHARMACEUTICALS INC
TickerRIGL
CIK0001034842
BoerseUS
SektorHealthcare
IndustrieBiotechnology
SIC2834 · Pharmaceutical Preparations

Wertpapier & Kennzahlen

CUSIP766559603
ISINUS7665596034
TypCommon Stock
Marktkapitalisierung538,5 Mio. USD
Beta1,27
Dividendenrendite0,00 %

Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »

Finanzkennzahlen (SEC XBRL)

PeriodeFilingUmsatzNettoergebnisEPSAktivaEigenkapital
2025-12-3110-K294,282,000367,024,00019.48513,594,000391,480,000
2025-09-3010-Q69,462,00027,900,0001.46242,534,000117,609,000
2025-06-3010-Q101,685,00059,613,0003.28206,736,00081,934,000
2025-03-3110-Q53,333,00011,446,0000.63175,972,00018,567,000
2024-12-3110-K179,278,00017,485,0000.99163,976,0003,288,000
2024-09-3010-Q55,307,00012,421,0000.70139,419,000-14,636,000
2024-06-3010-Q36,841,000-1,030,000-0.06128,408,000-29,914,000
2024-03-3110-Q29,534,000-8,247,000-0.47126,519,000-31,671,000
2023-12-3110-K116,882,000-25,091,000-1.44117,225,000-28,644,000
2023-09-3010-Q28,134,000-5,692,000-0.33115,324,000-31,834,000
2023-06-3010-Q26,886,000-6,600,000-0.38117,091,000-28,115,000
2023-03-3110-Q26,070,000-13,536,000-0.08123,612,000-24,257,000
2022-12-3110-K120,242,000-58,573,000-3.44134,279,000-13,616,000
2022-09-3010-Q22,410,000-19,037,000-0.11115,609,000-19,834,000
2022-06-3010-Q29,819,000-13,492,000-0.08128,001,000-3,677,000
2022-03-3110-Q16,735,000-27,445,000-0.16149,074,0006,798,000
2021-12-3110-K149,236,000-17,914,000-0.11167,328,00030,374,000
2021-09-3010-Q21,543,000-20,952,000-0.12186,518,00049,670,000
2021-06-3010-Q26,266,000-13,821,000-0.08201,598,00068,110,000
2021-03-3110-Q81,018,00039,500,0000.22215,993,00078,298,000

Fondsaktivität (Vorquartalsvergleich)

FondsAktuell (Stk)Vorquartal (Stk)Veränderung (Stk)Wert (USD)StatusΔTrend
BlackRock, Inc.1,664,21001,664,21071,278,114Neu+100,0%
STATE STREET CORP1,091,22301,091,22346,737,081Neu+100,0%
VANGUARD GROUP INC1,038,40801,038,40844,475,015Neu+100,0%
GOLDMAN SACHS GROUP INC671,8780671,87828,776,535Neu+100,0%
MARSHALL WACE, LLP613,6000613,60026,280,489Neu+100,0%
RENAISSANCE TECHNOLOGIES LLC539,0090539,00923,085,755Neu+100,0%
MILLENNIUM MANAGEMENT LLC431,4600431,46018,479,432Neu+100,0%
GEODE CAPITAL MANAGEMENT, LLC424,3140424,31418,177,612Neu+100,0%
D. E. Shaw & Co., Inc.424,3160424,31618,173,454Neu+100,0%
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP413,6590413,65917,717,015Neu+100,0%
JANE STREET GROUP, LLC312,8830312,88313,400,779Neu+100,0%
Soleus Capital Management, L.P.300,0340300,03412,850,456Neu+100,0%
Qube Research & Technologies Ltd288,2690288,26912,346,561Neu+100,0%
DIMENSIONAL FUND ADVISORS LP276,8120276,81211,855,857Neu+100,0%
TWO SIGMA INVESTMENTS, LP271,2280271,22811,616,695Neu+100,0%
AMERICAN CENTURY COMPANIES INC254,4920254,49210,899,892Neu+100,0%
CITADEL ADVISORS LLC242,1190242,11910,369,957Neu+100,0%
CM Management, LLC225,0000225,0009,636,750Neu+100,0%
GLOBEFLEX CAPITAL L P217,8390217,8399,330,044Neu+100,0%
Trexquant Investment LP197,1480197,1488,443,849Neu+100,0%
MORGAN STANLEY166,4890166,4897,130,765Neu+100,0%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC148,6360148,6366,366,080Neu+100,0%
PRUDENTIAL FINANCIAL INC135,4280135,4285,800,381Neu+100,0%
SUSQUEHANNA INTERNATIONAL GROUP, LLP130,7810130,7815,601,350Neu+100,0%
NORTHERN TRUST CORP129,0220129,0225,526,011Neu+100,0%
ZACKS INVESTMENT MANAGEMENT119,0880119,0885,100,534Neu+100,0%
BANK OF AMERICA CORP /DE/116,9520116,9525,009,053Neu+100,0%
AQR CAPITAL MANAGEMENT LLC109,7360109,7364,699,993Neu+100,0%
O'SHAUGHNESSY ASSET MANAGEMENT, LLC107,9890107,9894,625,169Neu+100,0%
Connor, Clark & Lunn Investment Management Ltd.107,9690107,9694,624,312Neu+100,0%
RITHOLTZ WEALTH MANAGEMENT80,593080,5933,451,798Neu+100,0%
Empire Financial Management Company, LLC76,445076,4453,274,139Neu+100,0%
BARCLAYS PLC75,359075,3593,227,625Neu+100,0%
Brandywine Global Investment Management, LLC71,570071,5703,065,343Neu+100,0%
FMR LLC67,838067,8382,905,504Neu+100,0%
WELLS FARGO & COMPANY/MN61,999061,9992,655,417Neu+100,0%
WELLINGTON MANAGEMENT GROUP LLP57,001057,0012,441,354Neu+100,0%
Man Group plc56,688056,6882,427,947Neu+100,0%
Universal- Beteiligungs- und Servicegesellschaft mbH55,200055,2002,364,216Neu+100,0%
Squarepoint Ops LLC53,556053,5562,293,803Neu+100,0%
MASSACHUSETTS FINANCIAL SERVICES CO /MA/52,982052,9822,269,219Neu+100,0%
LOS ANGELES CAPITAL MANAGEMENT LLC66,060066,0602,088,817Neu+100,0%
UBS Group AG46,438046,4381,988,940Neu+100,0%
Range Financial Group LLC45,938045,9381,967,525Neu+100,0%
JACOBS LEVY EQUITY MANAGEMENT, INC44,487044,4871,905,378Neu+100,0%
RAYMOND JAMES FINANCIAL INC43,755043,7551,874,027Neu+100,0%
Advisory Services Network, LLC43,666043,6661,870,215Neu+100,0%
FRANKLIN RESOURCES INC41,023041,0231,757,015Neu+100,0%
Ruffer LLP37,244037,2441,597,533Neu+100,0%
SEGALL BRYANT & HAMILL, LLC37,256037,2561,595,674Neu+100,0%

Insider-Transaktionen (12 Monate)

Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.

Top-Fondshalter

Hinweis: Keine aktuelleren Daten zu dieser Aktie verfuegbar. Stand der gezeigten 13F-Holdings: 31.12.2025. Letztes global veroeffentlichtes 13F-Quartal: 31.03.2026.

FondsAnteileWert (USD)Anteil (%)
BlackRock, Inc.1,664,21071,278,11412.88
STATE STREET CORP1,091,22346,737,0818.45
VANGUARD GROUP INC1,038,40844,475,0158.04
GOLDMAN SACHS GROUP INC671,87828,776,5355.20
MARSHALL WACE, LLP613,60026,280,4894.75
RENAISSANCE TECHNOLOGIES LLC539,00923,085,7554.17
MILLENNIUM MANAGEMENT LLC431,46018,479,4323.34
GEODE CAPITAL MANAGEMENT, LLC424,31418,177,6123.29
D. E. Shaw & Co., Inc.424,31618,173,4543.29
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP413,65917,717,0153.20
JANE STREET GROUP, LLC312,88313,400,7792.42
Soleus Capital Management, L.P.300,03412,850,4562.32
Qube Research & Technologies Ltd288,26912,346,5612.23
DIMENSIONAL FUND ADVISORS LP276,81211,855,8572.14
TWO SIGMA INVESTMENTS, LP271,22811,616,6952.10
AMERICAN CENTURY COMPANIES INC254,49210,899,8921.97
CITADEL ADVISORS LLC242,11910,369,9571.87
CM Management, LLC225,0009,636,7501.74
GLOBEFLEX CAPITAL L P217,8399,330,0441.69
Trexquant Investment LP197,1488,443,8491.53

Hinweis

Erweitert ×